Squarepoint
ELV icon

Squarepoint’s Elevance Health ELV Stock Holding History

Squarepoint’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.28M Sell
21,400
-17,300
-45% -$6.42M 0.01% 1233
2026
Q1 		$11.3M Sell
38,700
-36,300
-48% -$11.9M 0.01% 1007
2025
Q4 		$26.3M Sell
75,000
-32,100
-30% -$10.8M 0.03% 617
2025
Q3 		$34.6M Buy
107,100
+81,400
+317% +$25.3M 0.03% 532
2025
Q2 		$10M Sell
25,700
-6,800
-21% -$2.74M 0.01% 1067
2025
Q1 		$14.1M Sell
32,500
-52,700
-62% -$21.2M 0.02% 866
2024
Q4 		$31.4M Buy
85,200
+82,600
+3,177% +$34.6M 0.03% 553
2024
Q3 		$1.35M Buy
2,600
+2,200
+550% +$1.18M ﹤0.01% 2369
2024
Q2 		$217K Sell
400
-600
-60% -$317K ﹤0.01% 3617
2024
Q1 		$519K Sell
1,000
-4,600
-82% -$2.29M ﹤0.01% 3024
2023
Q4 		$2.64M Buy
5,600
+2,400
+75% +$1.11M 0.01% 1817
2023
Q3 		$1.39M Sell
3,200
-2,100
-40% -$953K ﹤0.01% 2081
2023
Q2 		$2.35M Buy
5,300
+4,000
+308% +$1.85M 0.01% 1553
2023
Q1 		$598K Buy
+1,300
New +$619K ﹤0.01% 2202
2022
Q4 		– Sell
-700
Closed -$318K – 3280
2022
Q3 		$318K Sell
700
-10,200
-94% -$4.88M ﹤0.01% 2450
2022
Q2 		$5.26M Buy
10,900
+9,500
+679% +$4.7M 0.03% 650
2022
Q1 		$688K Buy
+1,400
New +$640K ﹤0.01% 1819
2021
Q4 		– Sell
-2,000
Closed -$746K – 3249
2021
Q3 		$746K Sell
2,000
-7,300
-78% -$2.77M ﹤0.01% 1740
2021
Q2 		$3.55M Buy
9,300
+800
+9% +$306K 0.01% 887
2021
Q1 		$3.05M Buy
+8,500
New +$2.73M 0.02% 859

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Squarepoint's ELV Position: Q2 2026 in Review

Squarepoint increased its Elevance Health (ELV) stake by 901% in Q2 2026, buying an estimated $21.7M and bringing the position to 64,879 shares worth $25.1M. The position accounts for 0.03% of the portfolio, ranked #593.

Squarepoint first reported a position in ELV in Q2 2015 and has held it in 41 quarters since. The position peaked at $217M in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Squarepoint held 64,879 shares of Elevance Health worth $25.1M as of Q2 2026.
  • Squarepoint bought 58,399 Elevance Health shares in Q2 2026, an estimated $21.7M.
  • Elevance Health made up 0.03% of Squarepoint's portfolio in Q2 2026, its #593 holding.
  • Squarepoint first reported a position in Elevance Health in Q2 2015 and has held it in 41 quarters since.
  • Squarepoint's Elevance Health position peaked at $217M in Q4 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.